Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine.

Autor:	Mok, C.C., To, C.H., Szeto, M.L.
Předmět:	PULMONARY fibrosis treatment DERMATOMYOSITIS POLYMYOSITIS ANTIRHEUMATIC agents COMBINATION drug therapy INTERSTITIAL lung diseases ORAL drug administration TREATMENT effectiveness CYCLOPHOSPHAMIDE DISEASE progression AZATHIOPRINE DISEASE complications PHARMACODYNAMICS
Zdroj:	Scandinavian Journal of Rheumatology; May2003, Vol. 32 Issue 3, p181-183, 3p, 2 Black and White Photographs
Abstrakt:	Interstitial lung disease (ILD) is a major complication of idiopathic inflammatory myopathies (IIM). We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis-related rapidly deteriorating ILD, resistant to steroid. Prompt recognition and early aggressive immunosuppressive therapy may improve the outlook of this condition. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu